Defining High-Risk Disease Biology in Multiple Myeloma: A Narrative Review
Blood and Lymphatic Cancer: Targets and Therapy · 2026-04 · Volume 16 · 1-7
DOI: 10.2147/blctt.s586948 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Blood and Lymphatic Cancer: Targets and Therapy, 2026-04. Verfasst von Mohammad Aljumaa und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology, Mayo Clinic, Rochester, MN, USA. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Hematology, Mayo Clinic, Rochester, MN, USA.
- College of Medicine, Alfaisal University, Riyadh, Saudi Arabia.
ORCID-Profile: Yogesh Chawla, Wilson I Gonsalves
Zitieren
APA
Aljumaa, M., Hamam Refai, H., Chawla, Y., & Gonsalves, W. I. (2026). Defining High-Risk Disease Biology in Multiple Myeloma: A Narrative Review. Blood and Lymphatic Cancer: Targets and Therapy, Volume 16, 1-7. https://doi.org/10.2147/blctt.s586948
Vancouver
Aljumaa M, Hamam Refai H, Chawla Y, Gonsalves WI. Defining High-Risk Disease Biology in Multiple Myeloma: A Narrative Review. Blood and Lymphatic Cancer: Targets and Therapy. 2026;Volume 16:1-7. doi:10.2147/blctt.s586948
BibTeX
@article{Aljumaa2026,
author = {Aljumaa, Mohammad and Hamam Refai, Hasan and Chawla, Yogesh and Gonsalves, Wilson I},
title = {Defining High-Risk Disease Biology in Multiple Myeloma: A Narrative Review},
journal = {Blood and Lymphatic Cancer: Targets and Therapy},
year = {2026},
volume = {Volume 16},
pages = {1--7},
doi = {10.2147/blctt.s586948}
}
EUVIMED